.Pharmacolibrary.Drugs.D_Dermatologicals.D01A_AntifungalsForTopicalUse.D01AC15_Fluconazole.Fluconazole_1 .Pharmacolibrary.Drugs.D_Dermatologicals.D01A_AntifungalsForTopicalUse.D01AC15_Fluconazole.Fluconazole_1| name: | Fluconazole_1 |
| ATC code: | D01AC15_1 | route: | intravenous |
| n-compartments | 1 |
Fluconazole is a triazole antifungal medication used to treat and prevent a variety of fungal and yeast infections, including candidiasis and cryptococcal meningitis. It is approved for use in many countries and is commonly prescribed both for systemic and superficial mycoses.
Pharmacokinetic parameters as reported in healthy adult volunteers after single intravenous dose.
Tanzawa, A, et al., & Yamatani, A (2022). Fluconazole Population Pharmacokinetics after Fosfluconazole Administration and Dosing Optimization in Extremely Low-Birth-Weight Infants. Microbiology spectrum 10(2) e0195221–None. DOI:10.1128/spectrum.01952-21 PUBMED:https://pubmed.ncbi.nlm.nih.gov/35266811
Wang, H, et al., & Li, X (2024). Population pharmacokinetics of fluconazole for prevention or treatment of invasive candidiasis in Chinese young infants. Naunyn-Schmiedeberg's archives of pharmacology 397(11) 8853–8862. DOI:10.1007/s00210-024-03184-7 PUBMED:https://pubmed.ncbi.nlm.nih.gov/38850301
Momper, JD, et al., & Benjamin, DK (2016). Population Pharmacokinetics of Fluconazole in Premature Infants with Birth Weights Less than 750 Grams. Antimicrobial agents and chemotherapy 60(9) 5539–5545. DOI:10.1128/AAC.00963-16 PUBMED:https://pubmed.ncbi.nlm.nih.gov/27401564